Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 4.85p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.85
  • 52 Week Low: 3.40
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 59,551
  • Market Cap: £25.87m

Eden Research gets product approvals in California and Florida

By Josh White

Date: Friday 12 May 2023

LONDON (ShareCast) - (Sharecast News) - Biopesticides developer Eden Research announced the receipt of regulatory approvals for its formulated products 'Cedroz' in California, and 'Mevalone' and 'Cedroz' in Florida on Friday.
The AIM-traded company said the approvals came after the United States Environmental Protection Agency (EPA) authorised six petitions submitted by Eden in September last year, opening up substantial revenue opportunities with a US market potential of around €94m for Mevalone and €189m for Cedroz.

Sales of the products were expected to begin in time for the 2024 growing season, with peak market penetration anticipated after three years.

Combined potential sales in the US were estimated at around €2.8m for Mevalone and €5.7m for Cedroz, based on peak sales, and a full label of all key target diseases and crops.

California and Florida were described as "essential markets" for Eden's products, due to the prevalence of high-value horticultural crops, including tomatoes, cucumbers, strawberries, oranges, and grapes.

Mevalone was approved in Florida for use on botrytis on table and wine grapes, while Cedroz was approved in both California and Florida for use on various nematode species affecting fruits and vegetables, including eggplant, peppers, tomatoes, cantaloupes, cucumbers, pumpkins, squash, zucchini, carrots, strawberries, and grapes.

"California and Florida are amongst the most significant addressable markets in the US, considering their production of high value crops," said chief executive officer Sean Smith.

"These approvals represent another important step in Eden's expansion into the United States - the world's second-largest food market.

"We look forward to sharing progress of our other applications in individual states from across the US in due course."

Smith said that as a "small but innovative" British business, Eden Research was "proud" of the impact it could have on the global stage.

"Our pioneering products and technologies are receiving regulatory approval and being distributed by our partners across Europe, Africa and now North America, accelerating change in the sustainable agricultural space globally."

At 1018 BST, shares in Eden Research were up 5.98% at 4.5p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 4.85p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.85
52 Week Low 3.40
Volume 59,551
Shares Issued 533.35m
Market Cap £25.87m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.63% below the market average20.63% below the market average20.63% below the market average20.63% below the market average20.63% below the market average
49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average
Price Trend
33.53% above the market average33.53% above the market average33.53% above the market average33.53% above the market average33.53% above the market average
62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average
Income Not Available
Growth
49.43% above the market average49.43% above the market average49.43% above the market average49.43% above the market average49.43% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average

Eden Research Dividends

No dividends found

Trades for 22-May-2024

Time Volume / Share Price
12:06 3,200 @ 4.90p
10:09 21,280 @ 4.72p
10:07 502 @ 5.00p
09:41 8,979 @ 4.72p
08:00 25,590 @ 4.73p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page